Cargando...
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy
Follicular lymphoma (FL) is a clinically and molecularly highly heterogeneous disease, yet prognostication relies predominantly on clinical tools. We recently demonstrated that integration of mutation status of 7 genes, including EZH2 and MEF2B, improves risk stratification. We mined gene expression...
Guardado en:
| Publicado en: | Blood |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Hematology
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5757687/ https://ncbi.nlm.nih.gov/pubmed/29122756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-08-799080 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|